NM_004006.3:c.1705-1G>T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_004006.3(DMD):c.1705-1G>T variant causes a splice acceptor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_004006.3 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMD | ENST00000357033.9 | c.1705-1G>T | splice_acceptor_variant, intron_variant | Intron 14 of 78 | 1 | NM_004006.3 | ENSP00000354923.3 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:1
- -
Duchenne muscular dystrophy Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Truncating variants in DMD are known to be pathogenic. While this particular variant has not been previously reported in the literature, it is likely to disrupt the splicing of exon 15 and a deletion of exon 15 has been previously reported in a Duchenne muscular dystrophy patient (PMID: 17854090). In addition, this variant has been shown to arise de novo in an affected individual undergoing testing at Invitae (Invitae database). This sequence change affects an acceptor splice site in intron 14. It is expected to disrupt mRNA splicing and likely results in a truncated or disrupted protein product. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at